ArticleMolecular and clinical oncology2020

Corticosteroids alleviate adverse events associated with enzalutamide in patients with metastatic castration-resistant prostate cancer.

Keita Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.